Drug Shortage Report for ATACAND PLUS

Last updated on 2019-03-14 History
Report ID 71992
Drug Identification Number 02332957
Brand name ATACAND PLUS
Common or Proper name candesartan cilexetil and hydrochlorothiazide tablets
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 25MG 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2 X 15 tablet blisters
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-01-21
Actual start date
Estimated end date 2019-03-15
Actual end date 2019-03-13
Shortage status Resolved
Updated date 2019-03-14
Company comments Fulfilling additional Health Canada requirements
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-03-14 English Compare
v10 2019-03-13 French Compare
v9 2019-03-13 English Compare
v8 2019-02-28 French Compare
v7 2019-02-28 English Compare
v6 2019-02-05 French Compare
v5 2019-02-05 English Compare
v4 2019-01-22 English Compare
v3 2019-01-11 French Compare
v2 2019-01-11 English Compare
v1 2019-01-11 English Compare